BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 2320135)

  • 21. The first DRG: lessons from the end stage renal disease program for the prospective payment system.
    Maxwell JH; Sapolsky HM
    Inquiry; 1987; 24(1):57-67. PubMed ID: 2951335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ESRD health care screens spell increasing regulation for dialysis facilities.
    Riley JB; Pristave RJ
    Nephrol News Issues; 1991 Feb; 5(2):20-1, 30. PubMed ID: 1997871
    [No Abstract]   [Full Text] [Related]  

  • 23. The direction of end-stage renal disease reimbursement in the United States.
    Lockridge RS
    Semin Dial; 2004; 17(2):125-30. PubMed ID: 15043614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Court invalidates parts of Medicare ESRD payment plan.
    Peterson RN; Pristave RJ
    Health Law Vigil; 1984 Sep; 7(19):7-12. PubMed ID: 10299657
    [No Abstract]   [Full Text] [Related]  

  • 25. Medicare program; clarification of resumption of entitlement rules for Medicare patients with end-stage renal disease (ESRD)--HCFA. Final rule.
    Fed Regist; 1995 May; 60(88 Pt 1):22533-5. PubMed ID: 10142805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New HCFA rule may impact social work services in ESRD facilities.
    Callahan MB
    Nephrol News Issues; 1998 Sep; 12(9):10-1. PubMed ID: 9923290
    [No Abstract]   [Full Text] [Related]  

  • 27. For patients' sake, we need a renal ACO.
    Neumann ME
    Nephrol News Issues; 2011 Jul; 25(8):8, 42. PubMed ID: 21877617
    [No Abstract]   [Full Text] [Related]  

  • 28. Understanding financial risk models: Implicationsfor nephrology practices and dialysis centers.
    Cellini GL
    Nephrol News Issues; 2016 Mar; 30(3):26-8, 30-3. PubMed ID: 27169216
    [No Abstract]   [Full Text] [Related]  

  • 29. Management of end-stage renal disease in Alabama.
    Melnick S
    Ala J Med Sci; 1983 Oct; 20(4):456-9. PubMed ID: 6359945
    [No Abstract]   [Full Text] [Related]  

  • 30. Reports from the ESRD Networks.
    Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S1-S104. PubMed ID: 11184738
    [No Abstract]   [Full Text] [Related]  

  • 31. The dialysis facility of the future: the financial and social environment.
    Steinman TI
    Semin Nephrol; 1997 Jul; 17(4):298-305. PubMed ID: 9241715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can we revitalize the ESRD program?
    McFeeley T
    Nephrol News Issues; 2004 Apr; 18(5):42-3, 47, 87. PubMed ID: 15125164
    [No Abstract]   [Full Text] [Related]  

  • 33. The economic cost of dialysis: a comparison between peritoneal dialysis and in-center hemodialysis in a Spanish unit.
    Rodríguez-Carmona A; Perez Fontán M; Bouza P; García Falcón T; Valdés F
    Adv Perit Dial; 1996; 12():93-6. PubMed ID: 8865880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Why we need the option of more dialysis.
    Hodge MH
    Nephrol News Issues; 2006 Oct; 20(11):76, 78-9. PubMed ID: 17039973
    [No Abstract]   [Full Text] [Related]  

  • 35. How to make the new conditions for coverage work in your dialysis clinic: Teaching self-management: new conditions emphasize patient participation in care.
    Alt PS; Schatell D
    Nephrol News Issues; 2009 Jun; 23(7):36, 38, 40-1. PubMed ID: 19585808
    [No Abstract]   [Full Text] [Related]  

  • 36. The legislative and regulatory process in the end-stage renal disease (ESRD) program, 1973 through 1997.
    Hull AR
    Semin Nephrol; 1997 May; 17(3):160-9. PubMed ID: 9165645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proposed conditions for coverage directed toward dialysis facilities.
    Smetanka S
    Health Care Law Mon; 2005 Apr; ():3-11. PubMed ID: 15895752
    [No Abstract]   [Full Text] [Related]  

  • 38. Medicare HMOs reveal unique contracting strategies for new ESRD risk demonstration.
    Public Sect Contract Rep; 1997 May; 3(5):74-6. PubMed ID: 10174874
    [No Abstract]   [Full Text] [Related]  

  • 39. Medicare program; End Stage Renal Disease Program; responsibilities of network organizations--HCFA. Final rule.
    Fed Regist; 1988 Jan; 53(13):1617-20. PubMed ID: 10302132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of HCFA's revised billing instructions for kinetic modeling and recirculation tests.
    Rosenthal AF; Mahlke KF
    Nephrol News Issues; 1998 Feb; 12(2):12. PubMed ID: 9526364
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.